Loading company…
Nuo Therapeutics develops biodynamic therapies, led by Aurix, a wound-healing hematogel made from a patient's own platelets and plasma.
Founded in 2001 and headquartered in Gaithersburg, US, Nuo Therapeutics, Inc. develops biodynamic therapies to improve healing. Its flagship product, Aurix, is a hematogel made from the patient's own platelets and plasma and is sold to hospitals and clinics for chronic wounds and surgical recovery. CNF Investments acquired the company in January 2017, and Martin Rosendale is CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in